华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02563 华昊中天医药-B

已收盘 11-22 16:08:13

28.900

-0.150

-0.52%

最高29.400	最低28.200	成交量37.60万
今开29.000	昨收29.050	日振幅4.13%
总市值105.37亿	流通市值62.63亿	总股本3.65亿
成交额1,083万	换手率0.17%	流通股本2.17亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02563","market":"HK","secType":"STK","nameCN":"华昊中天医药-B","latestPrice":28.9,"timestamp":1732262893015,"preClose":29.05,"halted":0,"volume":376000,"delay":0,"floatShares":216720857,"shares":364588000,"eps":0,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.15,"latestTime":"11-22 16:08:13","open":29,"high":29.4,"low":28.2,"amount":10825580,"amplitude":0.041308,"askPrice":28.9,"askSize":3800,"bidPrice":28.55,"bidSize":600,"shortable":0,"etf":0,"ttmEps":0,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"listingDate":1730304000000,"adjPreClose":29.05,"openAndCloseTimeList":[[1732239000000,1732248000000],[1732251600000,1732262400000]],"volumeRatio":1.163654,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02563","defaultTab":"news","newsList":[{"id":"2484610787","title":"华昊中天医药-B11月18日主力资金流出24万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2484610787","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484610787?lang=zh_cn&edition=full","pubTime":"2024-11-18 16:15","pubTimestamp":1731917756,"startTime":"0","endTime":"0","summary":"11月18日, 华昊中天医药-B股价跌0.17%，报收28.90元，成交金额918万元，换手率0.15%，振幅2.76%，量比1.19。华昊中天医药-B今日主力资金净流出24万元，连续3日净流出，上一交易日主力净流出21万元，今日环比增加14.29%。该股近5个交易日下跌1.37%，主力资金累计净流出66万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入129万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161626a24256fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118161626a24256fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","09939","BK1161","02563"],"gpt_icon":0},{"id":"2483348724","title":"华昊中天医药-B11月15日遭主力抛售21万元 环比增加950.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483348724","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483348724?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:15","pubTimestamp":1731658526,"startTime":"0","endTime":"0","summary":"11月15日, 华昊中天医药-B股价涨0.87%，报收28.95元，成交金额808万元，换手率0.13%，振幅4.88%，量比1.08。华昊中天医药-B今日主力资金净流出21万元，上一交易日主力净流出2万元，今日环比增加950.00%。该股近5个交易日上涨0.70%，主力资金累计净流入28万元；近20日主力资金累计净流入153万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161536abc3defc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161536abc3defc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","02563","09939"],"gpt_icon":0},{"id":"2483263847","title":"华昊中天医药-B(02563)与百洋智合签订市场推广服务协议及补充协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483263847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483263847?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:41","pubTimestamp":1731573694,"startTime":"0","endTime":"0","summary":"另外，公司、公司全资附属公司成都华昊中天药业有限公司及百洋智合签订市场推广服务协议补充协议。根据补充协议，各方同意授权百洋智合按照市场推广服务协议约定在指定区域内独占和排他地推广指定产品，且成都华昊中天将承继公司于市场推广服务协议项下的所有权利和义务。综上所述，董事会认为，订立市场推广服务协议及补充协议符合公司及股东的整体最佳利益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159938","09939","BK1574","BK1515","02563","BK1161"],"gpt_icon":0},{"id":"2481929163","title":"华昊中天医药-B11月07日获主力加仓104万元 环比增加10300.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481929163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481929163?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:16","pubTimestamp":1730967376,"startTime":"0","endTime":"0","summary":"11月07日, 华昊中天医药-B股价涨7.69%，报收28.00元，成交金额1931万元，换手率0.32%，振幅13.85%，量比0.58。华昊中天医药-B今日主力资金净流入104万元，连续4日净流入，上一交易日主力净流入1万元，今日环比增加10300.00%。该股近5个交易日上涨34.62%，主力资金累计净流入166万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入166万元，其中净流入天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107161643a21fc0e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107161643a21fc0e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09939","02563","BK1515","BK1574"],"gpt_icon":0},{"id":"2481916301","title":"华昊中天医药-B现涨逾11%创新高 较招股价已涨超80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481916301","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481916301?lang=zh_cn&edition=full","pubTime":"2024-11-07 11:34","pubTimestamp":1730950463,"startTime":"0","endTime":"0","summary":"华昊中天医药-B（02563）早盘涨超10%，高见29港元，较招股价16港元已涨超80%。截至发稿，股价上涨10.58%，现报28.75港元，成交额1414.98万港元。华昊中天成立于2002年，是一家合成生物学技术驱动的生物医药公司，致力于开发肿瘤创新药。公司的核心产品优替德隆注射液于2021年获得国家药监局批准上市时，销售均价为2388.71元/瓶，2022年被纳入国家医保药品目录，2023年3月1日谈判价格正式生效，该产品价格下降超过60%。但得益于医保放量，公司产品销量近年来相应有所增长。\n\n\r\n            责任编辑：栎树","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/07113445025149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02563","BK1574","159938","BK1515","BK1161","09939"],"gpt_icon":0},{"id":"1151420070","title":"异动解读 | 华昊中天医药核心肿瘤药物前景看好 上市定价策略助力股价大涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1151420070","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151420070?lang=zh_cn&edition=full","pubTime":"2024-11-07 11:20","pubTimestamp":1730949656,"startTime":"0","endTime":"0","summary":"港股沪昊中天医药-B股价今日盘中大涨9.42%,报28.25港元,引发市场关注。分析人士认为,华昊中天的核心产品优替德隆注射液前景看好,以及公司在港股上市时采取的\"套路回拨\"和\"惜售\"的定价策略是导致当日股价大涨的主要原因。华昊中天是一家合成生物学技术驱动的生物医药公司,专注肿瘤创新药研发。其核心产品优替德隆注射液于2021年获国家药监局批准上市,2022年被纳入国家医保目录。但华昊中天能否借助业绩持续支撑高估值仍有待观察。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02563"],"gpt_icon":0},{"id":"2481913780","title":"港股异动 | 华昊中天医药-B(02563)涨超10%创新高 较招股价已高80% 核心产品为优替德隆注射液","url":"https://stock-news.laohu8.com/highlight/detail?id=2481913780","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481913780?lang=zh_cn&edition=full","pubTime":"2024-11-07 11:15","pubTimestamp":1730949344,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华昊中天医药-B涨超10%，高见29港元，较招股价16港元已涨超80%。截至发稿，涨8.65%，报28.25港元，成交额1199.84万港元。但得益于医保放量，公司产品销量近年来相应有所增长。智通财经APP在《靠“套路回拨”助涨30%股价后，华昊中天医药-B拿什么撑起近80亿港元市值？》中指出，华昊中天医药上市首日的强势走势，与其套路回拨的玩法不无关系。加之华昊中天医药招股价上下限相差达到37%，并最终以下限定价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1207841.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","159938","BK1161","BK1515","09939","02563"],"gpt_icon":0},{"id":"2481888626","title":"华昊中天医药-B11月06日主力资金流入1万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481888626","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481888626?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:15","pubTimestamp":1730880941,"startTime":"0","endTime":"0","summary":"11月06日, 华昊中天医药-B股价跌0.95%，报收26.00元，成交金额445万元，换手率0.08%，振幅6.10%，量比0.00。华昊中天医药-B今日主力资金净流入1万元，连续3日净流入，上一交易日主力净流入35万元，今日环比减少97.14%。该股近5个交易日上涨62.50%，主力资金累计净流入62万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入62万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106161554a21bf2ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106161554a21bf2ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","BK1515","02563","BK1161"],"gpt_icon":0},{"id":"2480905346","title":"【IPO月报】10月港股IPO市场热度未减 卡罗特超购1346倍、华润饮料或成年度“冻资王”","url":"https://stock-news.laohu8.com/highlight/detail?id=2480905346","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480905346?lang=zh_cn&edition=full","pubTime":"2024-11-04 10:41","pubTimestamp":1730688108,"startTime":"0","endTime":"0","summary":"来源：港交所 整理：金吾财讯来源：港交所 整理：金吾财讯华润饮料或成年度“冻资王”顺带一提，10月以来接连两只新股挑战本年度“冻资王”称号。10月2日上市的卡罗特“冻资”1010.5亿港元，当时市场一度认为其将成为年度之最，但它在这个位置上仅坐了约20天。10月23日挂牌的包装水怡宝母公司华润饮料便以1323.9亿港元的冻结资金，夺得了本年度“冻资王”称号。不过，华润饮料目前收入仍以“怡宝”支撑。","market":"other","thumbnail":"https://static.szfiu.com/news/20200908/MDgyM2JhZGUzZDEwMDQ3MDAxNzk5NzY4NzQxNTI4.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgyM2JhZGUzZDEwMDQ3MDAxNzk5NzY4NzQxNTI4.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947017","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02549","HSCEI","02460","09639","02576","YANG","02567","BK1110","BK1200","BK1109","HSTECH","BK1148","02563"],"gpt_icon":1},{"id":"1190312549","title":"异动解读 | 华昊中天医药B股上市首日大涨27% 核心产品进医保+发行策略是主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1190312549","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190312549?lang=zh_cn&edition=full","pubTime":"2024-11-03 14:58","pubTimestamp":1730617132,"startTime":"0","endTime":"0","summary":"在11月1日的港股市场上,生物医药公司华昊中天医药B股上市首日即出现大涨行情,股价一度大涨27.16%,引发市场广泛关注。从相关新闻报道来看,这一上涨主要受到两大利好因素的驱动。华昊中天医药成立于2002年,专注于肿瘤创新药物的研发。在港股上市时,华昊中天医药采取了\"惜售+下限定价\"的发行策略,通过控制发售数量和定价来推高开盘股价。与上下限相差37%的发行价定在下限,导致上市后股价大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02563"],"gpt_icon":0},{"id":"2480021281","title":"华昊中天医药－Ｂ(02563)股价大幅上升15.385%，现价港币$24.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2480021281","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480021281?lang=zh_cn&edition=full","pubTime":"2024-11-01 14:33","pubTimestamp":1730442780,"startTime":"0","endTime":"0","summary":"[上升股]华昊中天医药－Ｂ(02563) 股价在下午02:33比前收市价大幅上升15.385%，现股价为港币$24.0。至目前为止，今日最高价为$24.0，而最低价为$20.8。总成交量为79.08万股，总成交金额为港币$1.8千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133719348_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2411012713/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02563","BK1161","09939","BK1515","BK1574","159938"],"gpt_icon":0},{"id":"1194695347","title":"异动解读 | 生物医药公司华昊中天医药B股上市首日大涨14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194695347","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194695347?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:50","pubTimestamp":1730433056,"startTime":"0","endTime":"0","summary":"港股生物医药公司华昊中天医药B股在2024年11月1日上市首日就出现大涨行情,盘中一度涨14.42%,引发市场广泛关注。据了解,华昊中天医药成立于2002年,是一家专注于肿瘤创新药物研发的合成生物学技术驱动型生物医药公司。分析人士认为,华昊中天医药上市首日的大涨与其在港股上市时采取的\"套路回拨\"和\"下限定价\"策略有关,通过控制发行数量和定价来推高首日股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02563"],"gpt_icon":0},{"id":"2480049382","title":"港股异动 | 华昊中天医药-B(02563)上市次日涨近14% 核心产品优替德隆注射液已进入医保","url":"https://stock-news.laohu8.com/highlight/detail?id=2480049382","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480049382?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:43","pubTimestamp":1730432608,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华昊中天医药-B上市次日涨近14%，截至发稿，涨7.21%，报22.3港元，成交额1293.99万港元。智通财经APP在《靠“套路回拨”助涨30%股价后，华昊中天医药-B拿什么撑起近80亿港元市值？》中指出，华昊中天医药上市首日的强势走势，与其套路回拨的玩法不无关系。正常情况来看，华昊中天医药公开发售认购获21.45倍认购，公开发售比例将增至30%。加之华昊中天医药招股价上下限相差达到37%，并最终以下限定价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09939","159938","02563","BK1161","BK1515"],"gpt_icon":0},{"id":"2479709030","title":"【IPO追踪】上市首日上演过山车，华昊中天商业化待提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2479709030","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479709030?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:53","pubTimestamp":1730371989,"startTime":"0","endTime":"0","summary":"10月31日，生物医药公司华昊中天(02563.HK)正式登陆港交所。","market":"us","thumbnail":"https://images.finet.hk/photoLib/title/202410_1/ac72e5f7-cb39-44fa-8224-4c90e2d7b04b.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202410_1/ac72e5f7-cb39-44fa-8224-4c90e2d7b04b.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/6723619553243c03f8d58db2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02473","01354","BK1137","BK1227","BK1239","BK1148","BK1155","01111","06181","02563","02550","BK1140","02477","02535"],"gpt_icon":0},{"id":"2479704263","title":"华昊中天医药港股上市：年亏损1.9亿 募资2亿 公司市值76亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479704263","media":"雷递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479704263?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:47","pubTimestamp":1730371673,"startTime":"0","endTime":"0","summary":"华昊中天此次发行价为16港元，位于发行区间16港元到22港元的最底部。华昊中天此次发售1458.8万股，募资总额为2.33亿港元。华昊中天开盘价为21.5港元，较发行价上涨34%；收盘价为20.8元，较发行价上涨30%；以收盘价计算，公司市值75.83亿港元。截至2024年5月31日，华昊中天持有的现金及现金等价物为3593万元。华昊中天2020年11月完成E轮融资时，每股成本128.3元，估值44.9亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031191408ab8ad615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031191408ab8ad615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02563"],"gpt_icon":0},{"id":"2479706643","title":"靠“套路回拨”助涨30%股价后，华昊中天医药-B(02563)拿什么撑起近80亿港元市值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2479706643","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479706643?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:35","pubTimestamp":1730370925,"startTime":"0","endTime":"0","summary":"在此背景下，港股“合成生物学第一股”华昊中天医药-B的上市首秀却有不一样的表现。截止收盘，华昊中天医药涨幅为30%，报20.8港元，成交额为6953.88万港元 ，总市值为75.83亿港元。在10月30日的暗盘交易中，华昊中天医药以20.90港元报价收盘，较招股价16港元上涨30.62%，每手200股，不计手续费，每手赚980港元。再遇套路回拨华昊中天医药上市首日的强势走势，与其套路回拨的玩法不无关系。认购资金方面，华昊中天医药此次全球发售净筹约1.96亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","BK1161","159938","02563","09939"],"gpt_icon":0},{"id":"2479877501","title":"【新股IPO】华昊中天医药(02563)首挂收报20.8港元 较招股价高30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479877501","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479877501?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:25","pubTimestamp":1730363134,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华昊中天医药(02563)首挂收报20.8港元，较招股价高30%，全日成交318.58万股，成交额6953.88万港元。不计手续费，每手200股，账面赚960港元。该股早盘开报21.5港元，较招股价高34.38%，全日最低价19.48港元，最高见25.95港元。最新总市值75.83亿港元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20220324/ZjY2ZWM0MjU3NTE0MTk1OTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/ZjY2ZWM0MjU3NTE0MTk1OTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946890","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","02563","BK1574","159938","09939"],"gpt_icon":0},{"id":"2479106757","title":"【新股IPO】华昊中天医药(02563)首挂盘中涨超48% 一手账面赚逾1500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479106757","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479106757?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:05","pubTimestamp":1730343934,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华昊中天医药(02563)首日挂牌表现强劲，截至发稿，报23.7港元，较招股价高48.13%，成交额5009.85万港元。以现价计，不计手续费，每手200股，账面赚1540港元。招股结果显示，股份下限定价16港元，集资总额约2.33亿港元，净额约1.96亿港元。每手200股，一手中签率4.45%，认购30手才可稳获一手。股份于公开发售部分认购额达21.45倍，国际配售部分认购额0.994倍。","market":"sg","thumbnail":"https://static.szfiu.com/news/20220324/Zjg3NTRmZmQ4NzliZGZjZTlkOWNiNmNkNjE2NDgwOTA5MTgxOTc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20220324/Zjg3NTRmZmQ4NzliZGZjZTlkOWNiNmNkNjE2NDgwOTA5MTgxOTc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946852","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1515","02563","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"2479146287","title":"港股异动 | 新股华昊中天医药-B(02563)涨逾60% 公司致力开发肿瘤创新药 优替德隆注射液为核心产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2479146287","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479146287?lang=zh_cn&edition=full","pubTime":"2024-10-31 10:40","pubTimestamp":1730342429,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，新股华昊中天医药-B首挂上市高开高走，盘中涨幅扩大逾60%。据悉，华昊中天成立于2002年，是一家合成生物学技术驱动的生物医药公司，致力于开发肿瘤创新药。华昊中天正在积极扩展优替德隆注射液的产品线，开发包括优替德隆胶囊、优替德隆纳米剂型和优替德隆抗体偶联药物在内的新产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1574","09939","159938","02563","159992","BK1161","06978"],"gpt_icon":0},{"id":"2479711307","title":"迈博药业-B盘中异动 股价大跌13.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479711307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479711307?lang=zh_cn&edition=full","pubTime":"2024-10-31 10:26","pubTimestamp":1730341612,"startTime":"0","endTime":"0","summary":"2024年10月31日早盘10时26分，迈博药业-B股票出现异动，股价大幅跳水13.89%。迈博药业-B股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，华昊中天医药-B、中生北控生物科技、和誉-B涨幅较大，振幅较大的相关个股有中生北控生物科技、华昊中天医药-B、方达控股，振幅分别为100.00%、37.19%、10.98%。该公司主要在中国境内经营业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103110265298e3f92c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103110265298e3f92c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02181","BK1574","BK1161","02563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biostar-pharm.com","stockEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.8156},{"period":"ytd","weight":0.8156}],"compareEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":-0.0438},{"period":"3month","weight":0.1129},{"period":"6month","weight":0.0533},{"period":"1year","weight":0.1052},{"period":"ytd","weight":0.1498}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京华昊中天生物医药股份有限公司是一家主要从事创新药研发、生产及销售的中国公司。该公司的产品及管线主要包括优替德隆注射液、优替德隆胶囊、优替德隆纳米剂型、优替德隆抗体偶联药物（ADC）、BG22、BG18和BG44。该公司的产品主要用于治疗复发或转移性乳腺癌、人类表皮生长因子受体2（HER2）阴性乳腺癌新辅助治疗、晚期非小细胞肺癌（NSCLC）、实体瘤、乳腺癌脑转移、肺癌脑转移等脑部肿瘤适应症。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"华昊中天医药-B","nameEN":"BIOSTAR PHARM-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华昊中天医药-B,02563,华昊中天医药-B股票,华昊中天医药-B股票老虎,华昊中天医药-B股票老虎国际,华昊中天医药-B行情,华昊中天医药-B股票行情,华昊中天医药-B股价,华昊中天医药-B股市,华昊中天医药-B股票价格,华昊中天医药-B股票交易,华昊中天医药-B股票购买,华昊中天医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华昊中天医药-B(02563)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华昊中天医药-B(02563)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}